These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 7785464

  • 1. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L.
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [Abstract] [Full Text] [Related]

  • 2. Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L.
    J Bone Miner Res; 1992 May; 7(5):523-30. PubMed ID: 1319665
    [Abstract] [Full Text] [Related]

  • 3. Defective bone formation by Hyp mouse bone cells transplanted into normal mice: evidence in favor of an intrinsic osteoblast defect.
    Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L.
    J Bone Miner Res; 1992 Feb; 7(2):215-20. PubMed ID: 1315116
    [Abstract] [Full Text] [Related]

  • 4. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
    Meyer MH, Meyer RA.
    J Bone Miner Res; 1988 Apr; 3(2):151-7. PubMed ID: 3213610
    [Abstract] [Full Text] [Related]

  • 5. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice.
    Ono T, Tanaka H, Yamate T, Nagai Y, Nakamura T, Seino Y.
    Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218
    [Abstract] [Full Text] [Related]

  • 6. Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS, Jones G.
    J Clin Invest; 1990 May; 85(5):1450-5. PubMed ID: 2332500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma 24,25-dihydroxyvitamin D3 concentrations in X-linked hypophosphatemic mice: studies using mass fragmentographic and radioreceptor assays.
    Cunningham J, Coldwell RD, Jones G, Tenenhouse HS, Trafford DJ, Makin HL.
    J Bone Miner Res; 1990 Feb; 5(2):173-7. PubMed ID: 2316405
    [Abstract] [Full Text] [Related]

  • 10. Abnormal modulation of serum osteocalcin by dietary phosphate and 1,25-dihydroxyvitamin D3 in the hypophosphatemic mouse.
    Tsuji H, Cawthorn C, Ecarot B.
    J Bone Miner Res; 1996 Sep; 11(9):1234-40. PubMed ID: 8864897
    [Abstract] [Full Text] [Related]

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 12. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [Abstract] [Full Text] [Related]

  • 13. Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3.
    Yamamoto T, Ecarot B, Glorieux FH.
    Bone; 1992 Mar; 13(3):209-15. PubMed ID: 1322149
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Endocrinology; 1982 Sep; 111(3):904-11. PubMed ID: 6896684
    [Abstract] [Full Text] [Related]

  • 16. Defective bone formation by transplanted Hyp mouse bone cells into normal mice.
    Ecarot-Charrier B, Glorieux FH, Travers R, Desbarats M, Bouchard F, Hinek A.
    Endocrinology; 1988 Aug; 123(2):768-73. PubMed ID: 3293983
    [Abstract] [Full Text] [Related]

  • 17. Serum insulin-like growth factor binding protein-3 in the hypophosphatemic mouse: decreased activity and abnormal modulation by dietary phosphate.
    Moriwake T, Abribat T, Brazeau P, Ecarot B.
    J Bone Miner Res; 1995 Nov; 10(11):1698-704. PubMed ID: 8592946
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P.
    Miner Electrolyte Metab; 1985 Nov; 11(6):358-68. PubMed ID: 3877862
    [Abstract] [Full Text] [Related]

  • 19. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
    Tenenhouse HS, Jones G.
    Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
    [Abstract] [Full Text] [Related]

  • 20. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.